Argentina Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032)
Synopsis
The above chart is Argentina Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032)
Market Dynamics
argentina’s prothrombin complex concentrate (pcc) market is expected to witness consistent growth over the forecast period, 2018 to 2032. this growth is attributed to the increasing demand for the product from hospitals, clinics, and other healthcare organizations. pcc finds use in treating vitamin k deficiency, hereditary deficiency of factors ii, vii, ix, and x, and other related indications.
patients suffering from warfarin overdose, drug interactions, and liver diseases are in dire need of pcc for rapid reversal of anticoagulant activity. also, pcc is essential for post-surgery patients who need anticoagulation reversal and for hemostasis during certain orthopedic interventions. additionally, benefits such as enhanced patient safety, greater efficacy, and reduction in bleeding risk associated with the product are expected to drive the market growth further.
pccs are made from pooled, human-derived plasma from a variety of anonymous donors and are regulated by the european blood directive. they have a high content of vitamin k dependent clotting factors, making them ideal for rapidly reversing warfarin’s anticoagulation effects. further, the products feature safety advantages such as rapid action, predictable activity, uniform mixing characteristics, and ease of administration.
the production and market of pccs are regulated by government authorities and agencies and have varying regulations in different countries. for instance, in latin america, argentina does not allow the marketing of pccbf4 which is the most common pcc that is used world-wide. this factor could limit access to the product in argentina and potentially lead to a sluggish market growth.
to summarize, the growth of the argentinean prothrombin complex concentrate market is predicted to be steady in the coming years, mainly due to increasing demand for the product in hospitals and clinics. the government has limited access to the product in certain cases. this factor could hamper the market growth and create challenges for manufacturers of pccs in argentina.